Literature DB >> 10920282

Characterization of the interaction of TZT-1027, a potent antitumor agent, with tubulin.

T Natsume1, J Watanabe, S Tamaoki, N Fujio, K Miyasaka, M Kobayashi.   

Abstract

TZT-1027, a derivative of dolastatin 10 isolated from the Indian Ocean sea hare Dolabella auricularia in 1987 by Pettit et al., is a potent antimicrotubule agent. We have compared the activity of TZT-1027 with that of dolastatin 10 as well as the vinca alkaloids vinblastine (VLB), vincristine (VCR) and vindesine (VDS). TZT-1027 and dolastatin 10 inhibited microtubule polymerization concentration-dependently at 1 - 100 microM with IC50 values of 2.2 +/- 0.6 and 2.3 +/- 0.7 microM, respectively. VLB, VCR and VDS inhibited microtubule polymerization at 1 - 3 microM with IC50 values of 2.7 +/- 0.6, 1.6 +/- 0.4 and 1.6 +/- 0.2 microM, respectively, but showed a slight decrease in inhibitory effect at concentrations of 10 microM or more. TZT-1027 also inhibited monosodium glutamate-induced tubulin polymerization concentration-dependently at 0.3 - 10 microM, with an IC50 of 1.2 microM, whereas VLB was only effective at 0.3 - 3 microM, with an IC50 of 0.6 microM, and caused so-called "aggregation" of tubulin at 10 microM. Scatchard analysis of the binding data for [(3)H]VLB suggested one binding site (Kd 0.2 +/- 0.04 microM and Bmax 6.0 +/- 0.26 nM / mg protein), while that for [(3)H]TZT-1027 suggested two binding sites, one of high affinity (Kd 0.2 +/- 0.01 microM and Bmax 1.7 +/- 0.012 nM / mg protein) and the other of low affinity (Kd 10. 3 +/- 1.46 microM and Bmax 11.6 +/- 0.83 nM / mg protein). [(3)H]TZT-1027 was completely displaced by dolastatin 10 but only incompletely by VLB. [(3)H]VLB was completely displaced by dolastatin 10 and TZT-1027. Furthermore, TZT-1027 prevented [(3)H]VLB from binding to tubulin in a non-competitive manner according to Lineweaver-Burk analysis. TZT-1027 concentration-dependently inhibited both [(3)H]guanosine 5'-triphosphate (GTP) binding to and GTP hydrolysis on tubulin. VLB inhibited the hydrolysis of GTP on tubulin concentration-dependently to a lesser extent than TZT-1027, but no inhibitory effect of VLB on [(3)H]GTP binding to tubulin was evident even at 100 microM. Thus, TZT-1027 affected the binding of VLB to tubulin, but its binding site was not completely identical to that of VLB. TZT-1027 had a potent inhibitory effect on tubulin polymerization and differed from vinca alkaloids in its mode of action against tubulin polymerization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10920282      PMCID: PMC5926414          DOI: 10.1111/j.1349-7006.2000.tb01007.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  39 in total

1.  Microtubule assembly in the absence of added nucleotides.

Authors:  M L Shelanski; F Gaskin; C R Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  LU103793 (NSC D-669356): a synthetic peptide that interacts with microtubules and inhibits mitosis.

Authors:  M de Arruda; C A Cocchiaro; C M Nelson; C M Grinnell; B Janssen; A Haupt; T Barlozzari
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

4.  Preparation of tubulin from brain.

Authors:  R C Williams; J C Lee
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

5.  Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects of cellular microtubules.

Authors:  R Bai; S J Friedman; G R Pettit; E Hamel
Journal:  Biochem Pharmacol       Date:  1992-06-23       Impact factor: 5.858

6.  In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell lines.

Authors:  A Photiou; P Shah; L K Leong; J Moss; S Retsas
Journal:  Eur J Cancer       Date:  1997-03       Impact factor: 9.162

7.  Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro.

Authors:  R H Himes; R N Kersey; I Heller-Bettinger; F E Samson
Journal:  Cancer Res       Date:  1976-10       Impact factor: 12.701

8.  Interaction of marine toxin dolastatin 10 with porcine brain tubulin: competitive inhibition of rhizoxin and phomopsin A binding.

Authors:  Y Li; H Kobayashi; Y Hashimoto; R Shirai; A Hirata; K Hayashi; Y Hamada; T Shioiri; S Iwasaki
Journal:  Chem Biol Interact       Date:  1994-12       Impact factor: 5.192

9.  Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol.

Authors:  E ter Haar; R J Kowalski; E Hamel; C M Lin; R E Longley; S P Gunasekera; H S Rosenkranz; B W Day
Journal:  Biochemistry       Date:  1996-01-09       Impact factor: 3.162

10.  Antitumor activity of TZT-1027, a novel dolastatin 10 derivative.

Authors:  M Kobayashi; T Natsume; S Tamaoki; J Watanabe; H Asano; T Mikami; K Miyasaka; K Miyazaki; M Gondo; K Sakakibara; S Tsukagoshi
Journal:  Jpn J Cancer Res       Date:  1997-03
View more
  7 in total

Review 1.  Drug development from marine natural products.

Authors:  Tadeusz F Molinski; Doralyn S Dalisay; Sarah L Lievens; Jonel P Saludes
Journal:  Nat Rev Drug Discov       Date:  2008-12-19       Impact factor: 84.694

2.  Structural insight into the inhibition of tubulin by vinca domain peptide ligands.

Authors:  Anthony Cormier; Matthieu Marchand; Raimond B G Ravelli; Marcel Knossow; Benoît Gigant
Journal:  EMBO Rep       Date:  2008-09-12       Impact factor: 8.807

3.  Gene expression profiling of exposure to TZT-1027, a novel microtubule-interfering agent, in non-small cell lung cancer PC-14 cells and astrocytes.

Authors:  T Natsume; T Nakamura; Y Koh; M Kobayashi; N Saijo; K Nishio
Journal:  Invest New Drugs       Date:  2001       Impact factor: 3.850

4.  Interactions of halichondrin B and eribulin with tubulin.

Authors:  Ruoli Bai; Tam Luong Nguyen; James C Burnett; Onur Atasoylu; Murray H G Munro; George R Pettit; Amos B Smith; Rick Gussio; Ernest Hamel
Journal:  J Chem Inf Model       Date:  2011-05-13       Impact factor: 4.956

5.  TZT-1027, an antimicrotubule agent, attacks tumor vasculature and induces tumor cell death.

Authors:  M Otani; T Natsume; J I Watanabe; M Kobayashi; M Murakoshi; T Mikami; T Nakayama
Journal:  Jpn J Cancer Res       Date:  2000-08

6.  The novel microtubule-interfering agent TZT-1027 enhances the anticancer effect of radiation in vitro and in vivo.

Authors:  Y Akashi; I Okamoto; M Suzuki; K Tamura; T Iwasa; S Hisada; T Satoh; K Nakagawa; K Ono; M Fukuoka
Journal:  Br J Cancer       Date:  2007-05-01       Impact factor: 7.640

Review 7.  Marine-derived angiogenesis inhibitors for cancer therapy.

Authors:  Ying-Qing Wang; Ze-Hong Miao
Journal:  Mar Drugs       Date:  2013-03-15       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.